Cancer models for NIK and the noncanonical NF-κB pathway have been analyzed at various stages from TRAF2/3 or cIAP degradation, to accumulation of NIK itself, to IKKα and its phosphorylation by NIK, or finally by increased expression or translocation of the downstream transcription factor RelB [71]. This evidence concerns the gene NFKB1 and cancer.